Back

Randomised placebo controlled trial evaluating the safety and efficacy of intracoronary insulin like growth factor 1 post percutaneous intervention for acute myocardial infarction

27 August 2017 (15:35 - 16:25)
Organised by:
Congress Presentation Part of: What's hot in STEMI? Infarction acute phase STEMI ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Eugene Patrick McFadden

Cork University Hospital, Cork (Ireland)

6 More presentations in this session

Presentation thumbnail
The obesity paradox in ST elevation myocardial infarction treated with primary percutaneous coronary intervention: role of infarct size.
Doctor L. Bergamaschi (Bologna, IT)
Abstract Slides
Presentation thumbnail
Complete revascularisation versus stress echocardiography-guided revascularisation in patients with ST-segment elevation myocardial infarction and multivessel disease (CROSS-AMI): a clinical trial.
Doctor R. Calvino Santos (A Coruna, ES)
Abstract Slides
Presentation thumbnail
Prognostic risk stratification in myocardial infarction with non-obstructed coronaries (MINOCA) by conventional risk factors and cardiac magnetic resonance
Doctor A. Ghosh Dastidar (Bristol, GB)
Abstract Slides
Presentation thumbnail
The timing for elective percutaneous coronary intervention and in-hospital outcomes in patients with ST-segment elevation myocardial infarction
Doctor Q. Zhao (Beijing, CN)
Abstract Slides
Presentation thumbnail
High sensitivity troponin T is a stronger predictor than early infarct size determined by CMR for long-term ejection fraction
Doctor M. Mohammad (Lund, SE)
Abstract Slides

Access the full session

Session thumbnail
What's hot in STEMI?

The Event

Event poster

ESC Congress 2017

27 August 2017 15:35 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources